RB

R. Michael Baldwin

TI Theravance Biopharma R&D Ip: 3 patents #64 of 116Top 60%
📍 San Mateo, CA: #1,620 of 3,727 inventorsTop 45%
🗺 California: #149,087 of 386,348 inventorsTop 40%
Overall (All Time): #1,338,010 of 4,157,543Top 35%
3
Patents All Time

Issued Patents All Time

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
12351561 Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Adam D. Hughes, Melissa Fleury, Miroslav Rapta, Venkat R. Thalladi, David L. Bourdet 2025-07-08
11718591 Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof Adam D. Hughes, Melissa Fleury, Miroslav Rapta, Venkat R. Thalladi, Gene Timothy Fass +2 more 2023-08-08
10472335 Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Adam D. Hughes, Melissa Fleury, Miroslav Rapta, Venkat R. Thalladi, David L. Bourdet 2019-11-12